S2Medical AB (publ) (STO:S2M)

Sweden flag Sweden · Delayed Price · Currency is SEK
0.0101
+0.0004 (4.12%)
At close: Mar 27, 2026
Market Cap9.16M +14.2%
Revenue (ttm)16.13M +9.9%
Net Income-10.09M
EPS-0.01
Shares Out906.78M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume102,649
Average Volume1,007,559
Open0.0097
Previous Close0.0097
Day's Range0.0095 - 0.0101
52-Week Range0.0076 - 0.0300
Beta2.88
RSI54.53
Earnings DateApr 9, 2026

About S2Medical AB

S2Medical AB (publ) develops products for wound healing, infection control, and cosmeceuticals spectrum in Sweden. The company offers odor eliminator under the YNOLENS brand; IvaQ, a negative pressure wound therapy (NPWT) system; Instagraft, a technology designed to make skin transplantation even in non-specialist healthcare setting; ADMERCIN, a solution against antibiotic-resistant bacteria; and Epiprotect, a technology designed to protect and support wound healing by creating an environment for tissue recovery. It also provides Symbiovance, a... [Read more]

Sector Healthcare
Founded 2013
Employees 7
Stock Exchange Nasdaq Stockholm
Ticker Symbol S2M
Full Company Profile

Financial Performance

Financial Statements